IL17A and systemic lupus erythematosus: In this study, CKD-506 treatment significantly decreased the ratio of CD4−CD8− double negative T cells and serum level of IL-17 in a murine model of SLE, which also may have contributed to prevention of the pathogenesis of renal injury.